Accelerated Neuromodulation Therapy for Negative Symptoms of Schizophrenia
RecruitingNCT07428460Phase: NAStarted 2026-02-01
Summary
The goal of this clinical trial is to learn if an accelerated form of neuromodulation therapy can help improve negative symptoms of schizophrenia. Negative symptoms can include low motivation, reduced
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
65 Years
Locations
Institut Universitaire en Santé Mentale de MontréalMontreal, Quebec, Canada
Institut universitaire de santé mentale de Québec - Centre dQuébec, Quebec, Canada
McGill Lab for Computational Psychiatry and Translation - BuVerdun, Quebec, Canada
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07428460